Cheek Swab News and Research

RSS

AssureRx closes $11 million Series B financing

AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.

25 Mar 2011

AML patient raises awareness in community about national stem cell registry

By the age of 28, Dana Severson was already an Iraq war veteran, an accomplished clinical engineer, a wife and mother. Days following her daughter Genevieve's first birthday, Severson was faced with a reality that would turn her life upside down. After several weeks of experiencing severe headaches and extreme exhaustion, the young mother was diagnosed with acute myeloid leukemia.

16 Feb 2011

ArcticDx develops test to determine inherited risk for AMD

Established in 2007 and based in Toronto, ArcticDx has developed a test, Macula Risk-, the first of its kind and specifically designed to determine one's inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10% of individuals. ArcticDx will use the PBDF investment to undertake studies in support of a planned filing for Food and Drug Administration (FDA) approval for Macula Risk.

2 Nov 2010

Top treatments and tests for hair loss

August is National Hair Loss Awareness Month and it's an important time for men and women to talk to their doctors about the newest tests and treatments available to help them. Over 100 million Americans are affected - including 60 million men and 40 million women.

15 Jul 2010

DermaGenoma releases CelluliteDX Genetic Test for women

As summer swimsuit season heats up, women around the world will inspect their looks in the mirror. A majority of them will see cellulite - at some point - but a new genetic test may be able to help them avoid cellulite before anyone notices.

10 Jun 2010

Study confirms genetic overlap for susceptibility to COPD and lung cancer

New research shows genes that make smokers more likely to develop chronic obstructive pulmonary disease (COPD), or emphysema, are also closely linked to an increased likelihood of developing lung cancer, according to studies presented today at the American Thoracic Society's annual meeting.

18 May 2010

Absolute Match DNA specimen verification test introduced by AIBioTech

American International Biotechnology Services™ announces the launch of its Absolute Match™ DNA specimen verification test. The test, which will be performed through AIBioTech’s Fairfax Identity Laboratories™ division, provides absolute confidence for a patient undergoing a biopsy procedure that their specimen and diagnosis is their own.

23 Nov 2009

Registry to help patients in need of bone marrow transplants

Nearly 70 percent of patients needing a marrow transplant do not have a matching donor in their family, leaving minorities particularly vulnerable to finding a donor who can provide a perfect match of common tissue types, according to Be the Match®, a movement that engages the public to help patients in need of bone marrow or umbilical cord blood transplants.

5 Oct 2009

Interleukin Genetics reports positive results from clinical study on weight management

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today top-line positive results from a retrospective clinical study on weight management using patients who participated in a diet study previously reported in the Journal of the American Medical Association.

23 Sep 2009

Celera and Medco collaborate in KIF6 gene variant testing

Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases patient adherence with statin therapy. Current studies have suggested that only about 50 to 60 percent of the patients who receive a prescription for a lipid-lowering drug are taking the medication after six months.

23 Sep 2009

PsoriasisDX Genetic Test for Psoriatic arthritis launched

The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a progressive irreversible joint disease associated with psoriasis. It is estimated that 20% to 40% of psoriasis patients will eventually develop PsA.

16 Sep 2009

HIV/AIDS expert urges routine HIV testing

Two influential medical organizations, along with researchers at the University of Alabama at Birmingham (UAB), have announced they strongly recommend universal and routine testing for human immunodeficiency virus (HIV) to help curb the AIDS epidemic. HIV infects more than 30 million globally; during last year alone, more than 2 million worldwide died from AIDS, which is caused by HIV.

3 May 2009

Handheld device provides on-the-spot DNA analysis to test tolerance to prescription drugs

A handheld device to predict whether patients will respond adversely to medication is one step closer to the market, thanks to a new partnership.

18 Feb 2009

One in seven Americans over the age of 70 suffers from dementia

About 3.4 million people, or 13.9 percent of the population age 71 and older, have some form of dementia, the study found. As expected, the prevalence of dementia increased dramatically with age, from five percent of those aged 71 to 79 to 37.4 percent of those age 90 and older.

31 Oct 2007

Computer algorithm traces ancestry using anonymous DNA samples

A group of computer scientists, mathematicians, and biologists from around the world have developed a computer algorithm that can help trace the genetic ancestry of thousands of individuals in minutes, without any prior knowledge of their background.

21 Sep 2007